Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline step-up versus step-down versus standard regimen for smoking cessation
ACTRN12616000802404Phase 4Withdrawn
- Sponsor
- Aaron Drovandi
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of varenicline in nicotine dependence (3 arms), sponsored by Aaron Drovandi. Primary endpoints: Adverse event frequency, severity, and duration, Withdrawal symptom frequency, severity, and duration and 1 more. Planned start Dec 2016; status: withdrawn.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ACTRN12616000802404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000802404.